AFX-3721

N/A

Report date: 2023/01/07 22:56:49
NME

Base Information

Drug NameAFX-3721
Drug Alias NameAFX-3721
ClassificationSmall molecules
Mechanisms of ActionInterleukin 13 receptor modulatorsInterleukin-4 modulators
TargetsInterleukin 13 receptorInterleukin-4
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAfecta Pharmaceuticals IncLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAfecta Pharmaceuticals IncLeo Pharma Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A